In the Special Report entitled “Potassium Homeostasis in Health and Disease: A Scientific Workshop Cosponsored by the National Kidney Foundation and the American Society of Hypertension” that appeared in the December 2017 issue of AJKD (Kovesdy et al, volume 70, issue 6, pages 844-858), there was an error in the financial disclosure statement. The corrected statement is “Financial Disclosure: Dr Kovesdy is a consultant to Relypsa and Astra Zeneca. Dr Grams has a grant from the NKF. Dr Palmer reports receipt of consultancy and speaker fees from Relypsa and AstraZeneca.